<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35319903</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>03</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>19</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1522-1490</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>322</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>American journal of physiology. Regulatory, integrative and comparative physiology</Title>
          <ISOAbbreviation>Am J Physiol Regul Integr Comp Physiol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Angiotensin II inhibits the A-type K<sup>+</sup> current of hypothalamic paraventricular nucleus neurons in rats with heart failure: role of MAPK-ERK1/2 signaling.</ArticleTitle>
        <Pagination>
          <StartPage>R526</StartPage>
          <EndPage>R534</EndPage>
          <MedlinePgn>R526-R534</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1152/ajpregu.00308.2021</ELocationID>
        <Abstract>
          <AbstractText>Angiotensin II (ANG II)-mediated sympathohumoral activation constitutes a pathophysiological mechanism in heart failure (HF). Although the hypothalamic paraventricular nucleus (PVN) is a major site mediating ANG II effects in HF, the precise mechanisms by which ANG II influences sympathohumoral outflow from the PVN remain unknown. ANG II activates the ubiquitous intracellular MAPK signaling cascades, and recent studies revealed a key role for ERK1/2 MAPK signaling in ANG II-mediated sympathoexcitation in HF rats. Importantly, ERK1/2 was reported to inhibit the transient outward potassium current (<i>I</i><sub>A</sub>) in hippocampal neurons. Given that <i>I</i><sub>A</sub> is a critical determinant of the PVN neuronal excitability, and that downregulation of <i>I</i><sub>A</sub> in the brain has been reported in cardiovascular disease states, including HF, we investigated here whether ANG II modulates <i>I</i><sub>A</sub> in PVN neurons via the MAPK-ERK pathway, and, whether these effects are altered in HF rats. Patch-clamp recordings from identified magnocellular neurosecretory neurons (MNNs) and presympathetic (PS) PVN neurons revealed that ANG II inhibited <i>I</i><sub>A</sub> in both PVN neuronal types, both in sham and HF rats. Importantly, ANG II effects were blocked by inhibiting MAPK-ERK signaling as well as by inhibiting epidermal growth factor receptor (EGFR), a gateway to MAPK-ERK signaling. Although no differences in basal <i>I</i><sub>A</sub> magnitude were found between sham and HF rats under normal conditions, MAPK-ERK blockade resulted in significantly larger <i>I</i><sub>A</sub> in both PVN neuronal types in HF rats. Taken together, our studies show that ANG II-induced ERK1/2 activity inhibits <i>I</i><sub>A</sub>, an effect expected to increase the excitability of presympathetic and neuroendocrine PVN neurons, contributing in turn to the neurohumoral overactivity that promotes progression of the HF syndrome.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Roy</LastName>
            <ForeName>Ranjan K</ForeName>
            <Initials>RK</Initials>
            <AffiliationInfo>
              <Affiliation>Neuroscience Institute, Georgia State University, Atlanta, Georgia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ferreira-Neto</LastName>
            <ForeName>Hildebrando Candido</ForeName>
            <Initials>HC</Initials>
            <AffiliationInfo>
              <Affiliation>Neuroscience Institute, Georgia State University, Atlanta, Georgia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Felder</LastName>
            <ForeName>Robert B</ForeName>
            <Initials>RB</Initials>
            <Identifier Source="ORCID">0000-0002-1880-2605</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Cardiovascular Medicine, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Stern</LastName>
            <ForeName>Javier E</ForeName>
            <Initials>JE</Initials>
            <Identifier Source="ORCID">0000-0002-9310-0486</Identifier>
            <AffiliationInfo>
              <Affiliation>Neuroscience Institute, Georgia State University, Atlanta, Georgia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01 HL136149</GrantID>
            <Acronym>HL</Acronym>
            <Agency>NHLBI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>23</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Am J Physiol Regul Integr Comp Physiol</MedlineTA>
        <NlmUniqueID>100901230</NlmUniqueID>
        <ISSNLinking>0363-6119</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>11128-99-7</RegistryNumber>
          <NameOfSubstance UI="D000804">Angiotensin II</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000804" MajorTopicYN="N">Angiotensin II</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006333" MajorTopicYN="Y">Heart Failure</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020935" MajorTopicYN="N">MAP Kinase Signaling System</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010286" MajorTopicYN="Y">Paraventricular Hypothalamic Nucleus</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">EGFR</Keyword>
        <Keyword MajorTopicYN="N">ERK1-2</Keyword>
        <Keyword MajorTopicYN="N">angiotensin</Keyword>
        <Keyword MajorTopicYN="N">hypothalamus</Keyword>
        <Keyword MajorTopicYN="N">potassium</Keyword>
        <Keyword MajorTopicYN="N">sympathetic</Keyword>
      </KeywordList>
      <CoiStatement>R.B. Felder is a party to a patent application for a microparticle preparation designed to reduce brain ERK1/2 signaling in heart failure. None of the other authors has any conflicts of interest, financial or otherwise, to disclose.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2023</Year>
          <Month>6</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>23</Day>
          <Hour>17</Hour>
          <Minute>14</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35319903</ArticleId>
        <ArticleId IdType="pmc">PMC9076419</ArticleId>
        <ArticleId IdType="doi">10.1152/ajpregu.00308.2021</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>McKinley MJ, Albiston AL, Allen AM, Mathai ML, May CN, McAllen RM, Oldfield BJ, Mendelsohn FA, Chai SY. The brain renin-angiotensin system: location and physiological roles. Int J Biochem Cell Biol
35: 901–918, 2003. doi:10.1016/s1357-2725(02)00306-0. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s1357-2725(02)00306-0</ArticleId>
            <ArticleId IdType="pubmed">12676175</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fink GD. Long-term sympatho-excitatory effect of angiotensin II: a mechanism of spontaneous and renovascular hypertension. Clin Exp Pharmacol Physiol
24: 91–95, 1997. doi:10.1111/j.1440-1681.1997.tb01789.x. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1440-1681.1997.tb01789.x</ArticleId>
            <ArticleId IdType="pubmed">9043812</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Osborn JW, Fink GD, Sved AF, Toney GM, Raizada MK. Circulating angiotensin II and dietary salt: converging signals for neurogenic hypertension. Curr Hypertens Rep
9: 228–235, 2007. doi:10.1007/s11906-007-0041-3. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11906-007-0041-3</ArticleId>
            <ArticleId IdType="pubmed">17519130</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang ZH, Francis J, Weiss RM, Felder RB. The renin-angiotensin-aldosterone system excites hypothalamic paraventricular nucleus neurons in heart failure. Am J Physiol Heart Circ Physiol
283: H423–H433, 2002. doi:10.1152/ajpheart.00685.2001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpheart.00685.2001</ArticleId>
            <ArticleId IdType="pubmed">12063317</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zucker IH. Novel mechanisms of sympathetic regulation in chronic heart failure. Hypertension
48: 1005–1011, 2006. doi:10.1161/01.HYP.0000246614.47231.25. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.HYP.0000246614.47231.25</ArticleId>
            <ArticleId IdType="pubmed">17015773</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Francis J, Wei SG, Weiss RM, Felder RB. Brain angiotensin-converting enzyme activity and autonomic regulation in heart failure. Am J Physiol Heart Circ Physiol
287: H2138–H2146, 2004. doi:10.1152/ajpheart.00112.2004. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpheart.00112.2004</ArticleId>
            <ArticleId IdType="pubmed">15475532</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu Y, Wei SG, Weiss RM, Felder RB. Angiotensin II type 1a receptors in the subfornical organ modulate neuroinflammation in the hypothalamic paraventricular nucleus in heart failure rats. Neuroscience
381: 46–58, 2018. doi:10.1016/j.neuroscience.2018.04.012. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuroscience.2018.04.012</ArticleId>
            <ArticleId IdType="pmc">PMC5960439</ArticleId>
            <ArticleId IdType="pubmed">29684507</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bains JS, Potyok A, Ferguson AV. Angiotensin II actions in paraventricular nucleus: functional evidence for neurotransmitter role in efferents originating in subfornical organ. Brain Res
599: 223–229, 1992. doi:10.1016/0006-8993(92)90395-p.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0006-8993(92)90395-p</ArticleId>
            <ArticleId IdType="pubmed">1363284</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cato MJ, Toney GM. Angiotensin II excites paraventricular nucleus neurons that innervate the rostral ventrolateral medulla: an in vitro patch-clamp study in brain slices. J Neurophysiol
93: 403–413, 2005. doi:10.1152/jn.01055.2003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/jn.01055.2003</ArticleId>
            <ArticleId IdType="pmc">PMC3679885</ArticleId>
            <ArticleId IdType="pubmed">15356186</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferguson AV. Angiotensinergic regulation of autonomic and neuroendocrine outputs: critical roles for the subfornical organ and paraventricular nucleus. Neuroendocrinology
89: 370–376, 2009. doi:10.1159/000211202. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000211202</ArticleId>
            <ArticleId IdType="pubmed">19342823</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kang YM, Ma Y, Elks C, Zheng JP, Yang ZM, Francis J. Cross-talk between cytokines and renin-angiotensin in hypothalamic paraventricular nucleus in heart failure: role of nuclear factor-κB. Cardiovasc Res
79: 671–678, 2008. doi:10.1093/cvr/cvn119. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cvr/cvn119</ArticleId>
            <ArticleId IdType="pmc">PMC2732061</ArticleId>
            <ArticleId IdType="pubmed">18469338</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leenen FH. Brain mechanisms contributing to sympathetic hyperactivity and heart failure. Circ Res
101: 221–223, 2007. doi:10.1161/CIRCRESAHA.107.158261. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCRESAHA.107.158261</ArticleId>
            <ArticleId IdType="pubmed">17673679</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wei SG, Yu Y, Zhang ZH, Weiss RM, Felder RB. Angiotensin II-triggered p44/42 mitogen-activated protein kinase mediates sympathetic excitation in heart failure rats. Hypertension
52: 342–350, 2008. doi:10.1161/HYPERTENSIONAHA.108.110445. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.108.110445</ArticleId>
            <ArticleId IdType="pmc">PMC2785116</ArticleId>
            <ArticleId IdType="pubmed">18574076</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guggilam A, Patel KP, Haque M, Ebenezer PJ, Kapusta DR, Francis J. Cytokine blockade attenuates sympathoexcitation in heart failure: cross-talk between nNOS, AT-1R and cytokines in the hypothalamic paraventricular nucleus. Eur J Heart Fail
10: 625–634, 2008. doi:10.1016/j.ejheart.2008.05.004. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejheart.2008.05.004</ArticleId>
            <ArticleId IdType="pmc">PMC2593148</ArticleId>
            <ArticleId IdType="pubmed">18550427</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sharma NM, Llewellyn TL, Zheng H, Patel KP. Angiotensin II-mediated posttranslational modification of nNOS in the PVN of rats with CHF: role for PIN. Am J Physiol Heart Circ Physiol
305: H843–H855, 2013. doi:10.1152/ajpheart.00170.2013. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpheart.00170.2013</ArticleId>
            <ArticleId IdType="pmc">PMC3761348</ArticleId>
            <ArticleId IdType="pubmed">23832698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zheng H, Li Y-F, Wang W, Patel KP. Enhanced angiotensin-mediated excitation of renal sympathetic nerve activity within the paraventricular nucleus of anesthetized rats with heart failure. Am J Physiol Regul Integr Comp Physiol
297: R1364–R1374, 2009. doi:10.1152/ajpregu.00149.2009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpregu.00149.2009</ArticleId>
            <ArticleId IdType="pmc">PMC2777778</ArticleId>
            <ArticleId IdType="pubmed">19710393</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu Y, Zhang ZH, Wei SG, Weiss RM, Felder RB. Peroxisome proliferator-activated receptor-γ regulates inflammation and renin-angiotensin system activity in the hypothalamic paraventricular nucleus and ameliorates peripheral manifestations of heart failure. Hypertension
59: 477–484, 2012. doi:10.1161/HYPERTENSIONAHA.111.182345. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.111.182345</ArticleId>
            <ArticleId IdType="pmc">PMC3266457</ArticleId>
            <ArticleId IdType="pubmed">22083161</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bains JS, Ferguson AV. Angiotensin II neurotransmitter actions in paraventricular nucleus are potentiated by a nitric oxide synthase inhibitor. Regul Pept
50: 53–59, 1994. doi:10.1016/0167-0115(94)90191-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0167-0115(94)90191-0</ArticleId>
            <ArticleId IdType="pubmed">7512740</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Z-H, Francis J, Weiss RM, Felder R. The brain renin angiotensin system contributes to hyperexcitability of hypothalamic paraventricular nucleus neurons in congestive heart failure (Abstract). Circulation
102: 1715, 2000. </Citation>
        </Reference>
        <Reference>
          <Citation>Latchford KJ, Ferguson AV. Angiotensin depolarizes parvocellular neurons in paraventricular nucleus through modulation of putative nonselective cationic and potassium conductances. Am J Physiol Regul Integr Comp Physiol
289: R52–R58, 2005. doi:10.1152/ajpregu.00549.2004. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpregu.00549.2004</ArticleId>
            <ArticleId IdType="pubmed">15831764</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Z, Ferguson AV. Angiotensin II responsiveness of rat paraventricular and subfornical organ neurons in vitro. Neuroscience
55: 197–207, 1993. doi:10.1016/0306-4522(93)90466-s. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0306-4522(93)90466-s</ArticleId>
            <ArticleId IdType="pubmed">8394518</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stern JE, Son S, Biancardi VC, Zheng H, Sharma N, Patel KP. Astrocytes contribute to angiotensin II stimulation of hypothalamic neuronal activity and sympathetic outflow. Hypertension
68: 1483–1493, 2016. doi:10.1161/HYPERTENSIONAHA.116.07747.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.116.07747</ArticleId>
            <ArticleId IdType="pmc">PMC5159229</ArticleId>
            <ArticleId IdType="pubmed">27698069</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elsaafien K, Kirchner MK, Mohammed M, Eikenberry SA, West C, Scott KA, de Kloet AD, Stern JE, Krause EG. Identification of novel cross-talk between the neuroendocrine and autonomic stress axes controlling blood pressure. J Neurosci
41: 4641–4657, 2021. doi:10.1523/JNEUROSCI.0251-21.2021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.0251-21.2021</ArticleId>
            <ArticleId IdType="pmc">PMC8260250</ArticleId>
            <ArticleId IdType="pubmed">33858944</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kyriakis JM, Avruch J. Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. Physiol Rev
92: 689–737, 2012. doi:10.1152/physrev.00028.2011. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/physrev.00028.2011</ArticleId>
            <ArticleId IdType="pubmed">22535895</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thomas GM, Huganir RL. MAPK cascade signalling and synaptic plasticity. Nat Rev Neurosci
5: 173–183, 2004. doi:10.1038/nrn1346. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrn1346</ArticleId>
            <ArticleId IdType="pubmed">14976517</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wei SG, Yu Y, Zhang ZH, Felder RB. Angiotensin II upregulates hypothalamic AT1 receptor expression in rats via the mitogen-activated protein kinase pathway. Am J Physiol Heart Circ Physiol
296: H1425–H1433, 2009. doi:10.1152/ajpheart.00942.2008. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpheart.00942.2008</ArticleId>
            <ArticleId IdType="pmc">PMC2685358</ArticleId>
            <ArticleId IdType="pubmed">19286949</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wei SG, Yu Y, Zhang ZH, Weiss RM, Felder RB. Mitogen-activated protein kinases mediate upregulation of hypothalamic angiotensin II type 1 receptors in heart failure rats. Hypertension
52: 679–686, 2008. doi:10.1161/HYPERTENSIONAHA.108.113639. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.108.113639</ArticleId>
            <ArticleId IdType="pmc">PMC2790407</ArticleId>
            <ArticleId IdType="pubmed">18768402</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu Y, Wei SG, Zhang ZH, Weiss RM, Felder RB. ERK1/2 MAPK signaling in hypothalamic paraventricular nucleus contributes to sympathetic excitation in rats with heart failure after myocardial infarction. Am J Physiol Heart Circ Physiol
310: H732–H739, 2016. doi:10.1152/ajpheart.00703.2015. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpheart.00703.2015</ArticleId>
            <ArticleId IdType="pmc">PMC4865063</ArticleId>
            <ArticleId IdType="pubmed">26801309</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wei SG, Yu Y, Felder RB. TNF-α-induced sympathetic excitation requires EGFR and ERK1/2 signaling in cardiovascular regulatory regions of the forebrain. Am J Physiol Heart Circ Physiol
320: H772–H786, 2021. doi:10.1152/ajpheart.00606.2020. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpheart.00606.2020</ArticleId>
            <ArticleId IdType="pmc">PMC8082799</ArticleId>
            <ArticleId IdType="pubmed">33337962</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Adams JP, Anderson AE, Varga AW, Dineley KT, Cook RG, Pfaffinger PJ, Sweatt JD. The A-type potassium channel Kv4.2 is a substrate for the mitogen-activated protein kinase ERK. J Neurochem
75: 2277–2287, 2000. doi:10.1046/j.1471-4159.2000.0752277.x. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1471-4159.2000.0752277.x</ArticleId>
            <ArticleId IdType="pubmed">11080179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mao L-M, Wang JQ. Synaptically localized mitogen-activated protein kinases: local substrates and regulation. Mol Neurobiol
53: 6309–6315, 2016. doi:10.1007/s12035-015-9535-1. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12035-015-9535-1</ArticleId>
            <ArticleId IdType="pmc">PMC4867144</ArticleId>
            <ArticleId IdType="pubmed">26567109</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schrader LA, Birnbaum SG, Nadin BM, Ren Y, Bui D, Anderson AE, Sweatt JD. ERK/MAPK regulates the Kv4.2 potassium channel by direct phosphorylation of the pore-forming subunit. Am J Physiol Cell Physiol
290: C852–C861, 2006. doi:10.1152/ajpcell.00358.2005. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpcell.00358.2005</ArticleId>
            <ArticleId IdType="pubmed">16251476</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee SK, Lee S, Shin SY, Ryu PD, Lee SY. Single cell analysis of voltage-gated potassium channels that determines neuronal types of rat hypothalamic paraventricular nucleus neurons. Neuroscience
205: 49–62, 2012. doi:10.1016/j.neuroscience.2011.12.031. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuroscience.2011.12.031</ArticleId>
            <ArticleId IdType="pubmed">22245500</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sonner PM, Stern JE. Functional role of A-type potassium currents in rat presympathetic PVN neurones. J Physiol
582: 1219–1238, 2007. doi:10.1113/jphysiol.2007.134379. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1113/jphysiol.2007.134379</ArticleId>
            <ArticleId IdType="pmc">PMC2075254</ArticleId>
            <ArticleId IdType="pubmed">17525115</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bourque CW. Transient calcium-dependent potassium current in magnocellular neurosecretory cells of the rat supraoptic nucleus. J Physiol
397: 331–347, 1988. doi:10.1113/jphysiol.1988.sp017004. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1113/jphysiol.1988.sp017004</ArticleId>
            <ArticleId IdType="pmc">PMC1192128</ArticleId>
            <ArticleId IdType="pubmed">2457699</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luther JA, Tasker JG. Voltage-gated currents distinguish parvocellular from magnocellular neurones in the rat hypothalamic paraventricular nucleus. J Physiol
523: 193–209, 2000. doi:10.1111/j.1469-7793.2000.t01-1-00193.x. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1469-7793.2000.t01-1-00193.x</ArticleId>
            <ArticleId IdType="pmc">PMC2269788</ArticleId>
            <ArticleId IdType="pubmed">10673555</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sonner PM, Filosa JA, Stern JE. Diminished A-type potassium current and altered firing properties in presympathetic PVN neurones in renovascular hypertensive rats. J Physiol
586: 1605–1622, 2008. doi:10.1113/jphysiol.2007.147413. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1113/jphysiol.2007.147413</ArticleId>
            <ArticleId IdType="pmc">PMC2375712</ArticleId>
            <ArticleId IdType="pubmed">18238809</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Z, Ferguson AV. Electrophysiological properties of paraventricular magnocellular neurons in rat brain slices: modulation of IA by angiotensin II. Neuroscience
71: 133–145, 1996. doi:10.1016/0306-4522(95)00434-3. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0306-4522(95)00434-3</ArticleId>
            <ArticleId IdType="pubmed">8834397</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferreira-Neto HC, Biancardi VC, Stern JE. A reduction in SK channels contributes to increased activity of hypothalamic magnocellular neurons during heart failure. J Physiol
595: 6429–6442, 2017. doi:10.1113/JP274730.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1113/JP274730</ArticleId>
            <ArticleId IdType="pmc">PMC5638886</ArticleId>
            <ArticleId IdType="pubmed">28714070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Biancardi VC, Son SJ, Sonner PM, Zheng H, Patel KP, Stern JE. Contribution of central nervous system endothelial nitric oxide synthase to neurohumoral activation in heart failure rats. Hypertension
58: 454–463, 2011. doi:10.1161/HYPERTENSIONAHA.111.175810. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.111.175810</ArticleId>
            <ArticleId IdType="pmc">PMC3189581</ArticleId>
            <ArticleId IdType="pubmed">21825233</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stern JE. Electrophysiological and morphological properties of pre-autonomic neurones in the rat hypothalamic paraventricular nucleus. J Physiol
537: 161–177, 2001. doi:10.1111/j.1469-7793.2001.0161k.x. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1469-7793.2001.0161k.x</ArticleId>
            <ArticleId IdType="pmc">PMC2278924</ArticleId>
            <ArticleId IdType="pubmed">11711570</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Y, Zhang W, Stern JE. Nitric oxide inhibits the firing activity of hypothalamic paraventricular neurons that innervate the medulla oblongata: role of GABA. Neuroscience
118: 585–601, 2003. doi:10.1016/s0306-4522(03)00042-3. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0306-4522(03)00042-3</ArticleId>
            <ArticleId IdType="pubmed">12710969</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Naskar K, Stern JE. A functional coupling between extrasynaptic NMDA receptors and A-type K+ channels under astrocyte control regulates hypothalamic neurosecretory neuronal activity. J Physiol
592: 2813–2827, 2014. doi:10.1113/jphysiol.2014.270793. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1113/jphysiol.2014.270793</ArticleId>
            <ArticleId IdType="pmc">PMC4221822</ArticleId>
            <ArticleId IdType="pubmed">24835172</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Katz M, Amit I, Yarden Y. Regulation of MAPKs by growth factors and receptor tyrosine kinases. Biochim Biophys Acta
1773: 1161–1176, 2007. doi:10.1016/j.bbamcr.2007.01.002. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbamcr.2007.01.002</ArticleId>
            <ArticleId IdType="pmc">PMC2758354</ArticleId>
            <ArticleId IdType="pubmed">17306385</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bali A, Jaggi AS. Angiotensin II-triggered kinase signaling cascade in the central nervous system. Rev Neurosci
27: 301–315, 2016. doi:10.1515/revneuro-2015-0041. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1515/revneuro-2015-0041</ArticleId>
            <ArticleId IdType="pubmed">26574890</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sonner PM, Lee S, Ryu PD, Lee SY, Stern JE. Imbalanced K+ and Ca2+ subthreshold interactions contribute to increased hypothalamic presympathetic neuronal excitability in hypertensive rats. J Physiol
589: 667–683, 2011. doi:10.1113/jphysiol.2010.198556. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1113/jphysiol.2010.198556</ArticleId>
            <ArticleId IdType="pmc">PMC3055550</ArticleId>
            <ArticleId IdType="pubmed">21149460</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sundaram K, Johnson SM, Felder RB. Altered expression of delayed excitation in medial NTS neurons of spontaneously hypertensive rats. Neurosci Lett
225: 205–209, 1997. doi:10.1016/s0304-3940(97)00214-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0304-3940(97)00214-0</ArticleId>
            <ArticleId IdType="pubmed">9147406</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ludwig M, Leng G. Dendritic peptide release and peptide-dependent behaviours. Nat Rev Neurosci
7: 126–136, 2006. doi:10.1038/nrn1845. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrn1845</ArticleId>
            <ArticleId IdType="pubmed">16429122</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Son SJ, Filosa JA, Potapenko ES, Biancardi VC, Zheng H, Patel KP, Tobin VA, Ludwig M, Stern JE. Dendritic peptide release mediates interpopulation crosstalk between neurosecretory and preautonomic networks. Neuron
78: 1036–1049, 2013. doi:10.1016/j.neuron.2013.04.025.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuron.2013.04.025</ArticleId>
            <ArticleId IdType="pmc">PMC3884642</ArticleId>
            <ArticleId IdType="pubmed">23791197</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pitra S, Stern JE. A-type K+ channels contribute to the prorenin increase of firing activity in hypothalamic vasopressin neurosecretory neurons. Am J Physiol Heart Circ Physiol
313: H548–H557, 2017. doi:10.1152/ajpheart.00216.2017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpheart.00216.2017</ArticleId>
            <ArticleId IdType="pmc">PMC5625174</ArticleId>
            <ArticleId IdType="pubmed">28626074</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Kloet AD, Wang L, Pitra S, Hiller H, Smith JA, Tan Y, Nguyen D, Cahill KM, Sumners C, Stern JE, Krause EG. A unique “angiotensin-sensitive” neuronal population coordinates neuroendocrine, cardiovascular, and behavioral responses to stress. J Neurosci
37: 3478–3490, 2017. doi:10.1523/JNEUROSCI.3674-16.2017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.3674-16.2017</ArticleId>
            <ArticleId IdType="pmc">PMC5373130</ArticleId>
            <ArticleId IdType="pubmed">28219987</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mourão AA, Shimoura CG, Andrade MA, Truong TT, Pedrino GR, Toney GM. Local ionotropic glutamate receptors are required to trigger and sustain ramping of sympathetic nerve activity by hypothalamic paraventricular nucleus TNFα. Am J Physiol Heart Circ Physiol
321: H580–H591, 2021. doi:10.1152/ajpheart.00322.2021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpheart.00322.2021</ArticleId>
            <ArticleId IdType="pmc">PMC8461846</ArticleId>
            <ArticleId IdType="pubmed">34355986</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wee P, Wang Z. Epidermal growth factor receptor cell proliferation signaling pathways. Cancers (Basel)
9: 52, 2017. doi:10.3390/cancers9050052.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/cancers9050052</ArticleId>
            <ArticleId IdType="pmc">PMC5447962</ArticleId>
            <ArticleId IdType="pubmed">28513565</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Voldborg BR, Damstrup L, Spang-Thomsen M, Poulsen HS. Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials. Ann Oncol
8: 1197–1206, 1997. doi:10.1023/a:1008209720526. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1023/a:1008209720526</ArticleId>
            <ArticleId IdType="pubmed">9496384</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Konishi A, Berk BC. Epidermal growth factor receptor transactivation is regulated by glucose in vascular smooth muscle cells. J Biol Chem
278: 35049–35056, 2003. doi:10.1074/jbc.M304913200. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M304913200</ArticleId>
            <ArticleId IdType="pubmed">12829718</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pastore S, Mascia F, Mariani V, Girolomoni G. The epidermal growth factor receptor system in skin repair and inflammation. J Invest Dermatol
128: 1365–1374, 2008. doi:10.1038/sj.jid.5701184. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.jid.5701184</ArticleId>
            <ArticleId IdType="pubmed">18049451</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takeyama K, Dabbagh K, Jeong Shim J, Dao-Pick T, Ueki IF, Nadel JA. Oxidative stress causes mucin synthesis via transactivation of epidermal growth factor receptor: role of neutrophils. J Immunol
164: 1546–1552, 2000. doi:10.4049/jimmunol.164.3.1546. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.164.3.1546</ArticleId>
            <ArticleId IdType="pubmed">10640773</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taniguchi K, Xia L, Goldberg HJ, Lee KW, Shah A, Stavar L, Masson EA, Momen A, Shikatani EA, John R, Husain M, Fantus IG. Inhibition of Src kinase blocks high glucose-induced EGFR transactivation and collagen synthesis in mesangial cells and prevents diabetic nephropathy in mice. Diabetes
62: 3874–3886, 2013. doi:10.2337/db12-1010. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db12-1010</ArticleId>
            <ArticleId IdType="pmc">PMC3806624</ArticleId>
            <ArticleId IdType="pubmed">23942551</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Touyz RM, Wu XH, He G, Salomon S, Schiffrin EL. Increased angiotensin II-mediated Src signaling via epidermal growth factor receptor transactivation is associated with decreased C-terminal Src kinase activity in vascular smooth muscle cells from spontaneously hypertensive rats. Hypertension
39: 479–485, 2002. doi:10.1161/hy02t2.102909.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/hy02t2.102909</ArticleId>
            <ArticleId IdType="pubmed">11882594</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu Y, Wei SG, Weiss RM, Felder RB. Silencing epidermal growth factor receptor in hypothalamic paraventricular nucleus reduces extracellular signal-regulated kinase 1 and 2 signaling and sympathetic excitation in heart failure rats. Neuroscience
463: 227–237, 2021. doi:10.1016/j.neuroscience.2021.01.025. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuroscience.2021.01.025</ArticleId>
            <ArticleId IdType="pmc">PMC8106624</ArticleId>
            <ArticleId IdType="pubmed">33540053</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Potapenko ES, Biancardi VC, Florschutz RM, Ryu PD, Stern JE. Inhibitory-excitatory synaptic balance is shifted toward increased excitation in magnocellular neurosecretory cells of heart failure rats. J Neurophysiol
106: 1545–1557, 2011. doi:10.1152/jn.00218.2011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/jn.00218.2011</ArticleId>
            <ArticleId IdType="pmc">PMC3174805</ArticleId>
            <ArticleId IdType="pubmed">21697450</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Potapenko ES, Biancardi VC, Zhou Y, Stern JE. Altered astrocyte glutamate transporter regulation of hypothalamic neurosecretory neurons in heart failure rats. Am J Physiol Regul Integr Comp Physiol
303: R291–R300, 2012. doi:10.1152/ajpregu.00056.2012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpregu.00056.2012</ArticleId>
            <ArticleId IdType="pmc">PMC3423986</ArticleId>
            <ArticleId IdType="pubmed">22696576</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reis WL, Biancardi VC, Zhou Y, Stern JE. A functional coupling between carbon monoxide and nitric oxide contributes to increased vasopressin neuronal activity in heart failure rats. Endocrinology
157: 2052–2066, 2016. doi:10.1210/en.2015-1958.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/en.2015-1958</ArticleId>
            <ArticleId IdType="pmc">PMC4870874</ArticleId>
            <ArticleId IdType="pubmed">26982634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stern JE, Potapenko ES. Enhanced NMDA receptor-mediated intracellular calcium signaling in magnocellular neurosecretory neurons in heart failure rats. Am J Physiol Regul Integr Comp Physiol
305: R414–R422, 2013. doi:10.1152/ajpregu.00160.2013. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpregu.00160.2013</ArticleId>
            <ArticleId IdType="pmc">PMC3833393</ArticleId>
            <ArticleId IdType="pubmed">23785079</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hammond RS, Lin L, Sidorov MS, Wikenheiser AM, Hoffman DA. Protein kinase a mediates activity-dependent Kv4.2 channel trafficking. J Neurosci
28: 7513–7519, 2008. doi:10.1523/JNEUROSCI.1951-08.2008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.1951-08.2008</ArticleId>
            <ArticleId IdType="pmc">PMC2665045</ArticleId>
            <ArticleId IdType="pubmed">18650329</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang ZH, Yu Y, Kang YM, Wei SG, Felder RB. Aldosterone acts centrally to increase brain renin-angiotensin system activity and oxidative stress in normal rats. Am J Physiol Heart Circ Physiol
294: H1067–H1074, 2008. doi:10.1152/ajpheart.01131.2007. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpheart.01131.2007</ArticleId>
            <ArticleId IdType="pubmed">18162560</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang ZH, Yu Y, Wei SG, Felder RB. Aldosterone-induced brain MAPK signaling and sympathetic excitation are angiotensin II type-1 receptor dependent. Am J Physiol Heart Circ Physiol
302: H742–H751, 2012. doi:10.1152/ajpheart.00856.2011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpheart.00856.2011</ArticleId>
            <ArticleId IdType="pmc">PMC3353800</ArticleId>
            <ArticleId IdType="pubmed">22081704</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wei SG, Yu Y, Zhang ZH, Felder RB. Proinflammatory cytokines upregulate sympathoexcitatory mechanisms in the subfornical organ of the rat. Hypertension
65: 1126–1133, 2015. doi:10.1161/HYPERTENSIONAHA.114.05112. </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.114.05112</ArticleId>
            <ArticleId IdType="pmc">PMC4393369</ArticleId>
            <ArticleId IdType="pubmed">25776070</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
